These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13204385)

  • 1. Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione).
    BRODIE BB; YU TF; BURNS JJ; CHENKIN T; PATON BC; STEELE JM; GUTMAN AB
    Proc Soc Exp Biol Med; 1954; 86(4):884-7. PubMed ID: 13204385
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.
    YU TF; PATON BC; CHENKIN T; BURNS JJ; BRODIE BB; GUTMAN AB
    J Clin Invest; 1956 Apr; 35(4):374-85. PubMed ID: 13306779
    [No Abstract]   [Full Text] [Related]  

  • 3. [BLOOD LEVEL AND TRANSFER INTO THE FETAL BLOOD AND HUMAN MILK OF 1,2-DIPHENYL-4-N-BUTYL-3,5-PYRAZOLIDINEDIONE AND 1-PHENYL-2,3-DIMETHYL-4-ISOPROPYLAMINOPYRAZOLONE].
    GENSICHEN E; TAEGER F; KLINGMUELLER V
    Arzneimittelforschung; 1964 Apr; 14():248-52. PubMed ID: 14238563
    [No Abstract]   [Full Text] [Related]  

  • 4. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.
    BURNS JJ; YU TF; RITTERBAND A; PEREL JM; GUTMAN AB; BRODIE BB
    J Pharmacol Exp Ther; 1957 Mar; 119(3):418-26. PubMed ID: 13417097
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies of some drugs from the series of 1,2-diphenyl-3,5-pyrazolidinedione. III)].
    PICCININI F; MARAZZI-UBERTI E; TURBA C; COLOMBO-CORTI I
    Arch Int Pharmacodyn Ther; 1963 Feb; 141():480-9. PubMed ID: 13943253
    [No Abstract]   [Full Text] [Related]  

  • 6. The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure-activity relationship.
    Levesque L; Gaudreault RC; Marceau F
    Can J Physiol Pharmacol; 1991 Mar; 69(3):419-25. PubMed ID: 1647850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ASSESSMENT OF THE INSECTICIDAL ACTION OF SOME PYRAZOLONE DERIVATIVES].
    FAVOROVA LA; DOLGOV GF
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():7-11. PubMed ID: 14070209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione].
    LENFELD J; KROUTIL M; BOCEK M; CTVRTNIK J; MAYER J
    Arzneimittelforschung; 1961 Apr; 11():427-9. PubMed ID: 13760809
    [No Abstract]   [Full Text] [Related]  

  • 9. TREATMENT OF THE PATIENT WITH GOUT.
    DENKO CW
    Ohio State Med J; 1963 Nov; 59():1098-101. PubMed ID: 14083462
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of phenylbutazone (3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin) on renal function.
    CAMPBELL EF
    Proc Soc Exp Biol Med; 1953 Nov; 84(2):481-3. PubMed ID: 13121080
    [No Abstract]   [Full Text] [Related]  

  • 11. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract]   [Full Text] [Related]  

  • 12. [EDEMA INDUCED BY BRADYKININ AND ITS INHIBITION].
    LISIN N; LECLERCQ R; VANCAUWENBERGE H
    Rev Rhum Mal Osteoartic; 1963 Dec; 30():790-3. PubMed ID: 14116400
    [No Abstract]   [Full Text] [Related]  

  • 13. GOUT.
    REAH TG
    Practitioner; 1964 Sep; 193():306-14. PubMed ID: 14213731
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Anti-inflammatory, analgesic and antipyretic properties.
    Bianchi C; Lumachi B; Marazzi-Uberti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:183+. PubMed ID: 5067190
    [No Abstract]   [Full Text] [Related]  

  • 15. [ATTEMPTED INHIBITION OF BRADYKININ-INDUCED EDEMA IN RATS].
    LISIN N; LECLERCQ R
    C R Seances Soc Biol Fil; 1963 Dec; 157():1536-40. PubMed ID: 14091903
    [No Abstract]   [Full Text] [Related]  

  • 16. On the immunochemical specificity of pyrazolinone and pyrazolidinedione reactions.
    Schneider CH; Rolli H; Kasper MF
    Int J Immunopharmacol; 1990; 12(4):413-7. PubMed ID: 2391187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CONTRIBUTION TO THE EXPERIMENTAL STUDY OF A NEW ANTI-INFLAMMATORY AGENT, "A-230"].
    LISIN N
    Arch Int Pharmacodyn Ther; 1964 Oct; 151():429-39. PubMed ID: 14228056
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
    O'Reilly RA; Goulart DA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.
    BOSTROEM H; BERNTSEN K; WHITEHOUSE MW
    Biochem Pharmacol; 1964 Mar; 13():413-20. PubMed ID: 14157603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.